Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05356000 · ClinicalTrials.gov registry record · NA
GI Oxalate Absorption
A NA study of Bariatric Surgery Candidate and Kidney Stone, sponsored by University of Chicago.
- Recruiting
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT05356000: Recruiting NA study of Bariatric Surgery Candidate and Kidney Stone, sponsored by University of Chicago.
NCT05356000 is a NA study of Bariatric Surgery Candidate and Kidney Stone that is actively recruiting participants, run by University of Chicago. The registered enrollment target is 30 participants, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05356000, a NA study of Bariatric Surgery Candidate and Kidney Stone, is actively recruiting participants, sponsored by University of Chicago.
- RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to learn more about how oxalate, a compound found in many foods, may affect a person's chances of forming kidney stones. Active participation in this study will last for around one week. For the first two days, subjects will be asked to eat a special diet at home. From Days 3-5, they will eat special meals delivered to their home from a research clinic at the University of Chicago. They will also collect 24-hour urine samples at home on Days 4 and 5. On Day 6, they will come in to the research clinic at the University of Chicago in Hyde Park, where they will spend most of the day. They will receive a special liquid that contains oxalate, and we will have them eat a specially prepared breakfast that is low in oxalate and citrate.
Primary Outcome
24-hour urine oxalate will be measured before and after participants follow a low oxalate diet for 5 total days (3 days will be clinical research center prepared food with known measured oxalate content of 50mg/day)
Conditions Studied
Interventions
- OTHER Special low-oxalate diet followed by all-day visit to University of Chicago research clinic
Study Locations (1)
Illinois
- University of Chicago Medical Center - Chicago
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-01-25 |
| Est. Completion | 2026-08-02 |
| Phase | NA |
What NCT05356000 shows while recruiting
NCT05356000 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 112-participant average among 28 other Bariatric Surgery Candidate trials with a reported enrollment target (73% lower).
The record links to 2 conditions, with Bariatric Surgery Candidate appearing as the primary indexed condition, and to 1 intervention - of which Special low-oxalate diet followed by all-day visit to University of Chicago research clinic is the first listed.
NCT05356000 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT05356000 about?
NCT05356000 is a clinical study titled "GI Oxalate Absorption". This study aims to learn more about how oxalate, a compound found in many foods, may affect a person's chances of forming kidney stones. Active participation in this study will last for around one week. For the first two days, subjects will be asked to eat a special diet at home. From Days 3-5, the...
What is the current status of trial NCT05356000?
This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2023-01-25. Estimated completion is 2026-08-02.
What conditions does trial NCT05356000 study?
This clinical trial studies the following conditions: Bariatric Surgery Candidate, Kidney Stone.
What interventions are being tested in trial NCT05356000?
The interventions under investigation include: Special low-oxalate diet followed by all-day visit to University of Chicago research clinic (OTHER).
Who is sponsoring clinical trial NCT05356000?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05356000 being conducted?
This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bariatric Surgery Candidate
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05356000's enrollment target sits among peer trials
30 20th of 28 higher than 6 of 28 other Bariatric Surgery Candidate trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Bariatric Surgery Candidate trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Gut Microbiome and Sex as Risk Factors for Kidney Stones After Bariatric Surgery
RECRUITING · NA
-
Effects of Assisted Robotic vs Laparoscopic Sleeve Gastrectomy
RECRUITING · NA
-
Exercise, Brain Activity, and Weight Maintenance
RECRUITING · NA
-
RemI for Post-Bariatric Surgery Weight Regain
RECRUITING · NA
-
Postoperative VR for Recovery After Bariatric Surgery
ACTIVE NOT RECRUITING · NA
-
Single Anastomosis Duodenal Ileal Bypass (SADI) for Sleeve Revision
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI